CB vs PRCT · P/E 14, rev $59.40B vs rev $224.5M
Chubb Ltd (CB) versus Procept Biorobotics Corp (PRCT) — a side-by-side from cached financials, not a winner call.
Chubb Ltd (CB) is a insurance - property & casualty company listed on US.
Procept Biorobotics Corp (PRCT) is a medical devices company listed on US.
Latest reported CB revenue for 2025-12-31 was $59.40B. Net income was $10.31B. Revenue was up 6.5% from 2024-12-31 to 2025-12-31. CB currently screens at market cap $114.26B and trailing P/E 13.7.
Latest reported PRCT revenue for 2024-12-31 was $224.5M. Net income was -$91.4M. Revenue was up 64.8% from 2023-12-31 to 2024-12-31. PRCT currently screens at market cap $1.52B.
CB currently screens at market cap $114.26B and trailing P/E 13.7. PRCT currently screens at market cap $1.52B.
Not investment advice. Open the CB and PRCT stock pages for the full models.
Not investment advice.